Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02091648
Other study ID # R34HL107613
Secondary ID
Status Completed
Phase N/A
First received March 4, 2014
Last updated January 4, 2016
Start date January 2013
Est. completion date November 2015

Study information

Verified date January 2016
Source University of Pittsburgh
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The purpose of the proposed study is to conduct a randomized controlled pilot trial of a school-based stress management and coping skills training program among a sample of economically disadvantaged urban 8- to 12-year-old school children with physician-confirmed asthma. The investigators aim (1) to establish feasibility of this approach by recruiting from different schools and (2) to learn whether individuals assigned to receive the intervention show improvements in psychological function, decreases in lung inflammation, and related improvements in asthma health when compared with disease severity-matched peers who receive education-only or standard care.


Recruitment information / eligibility

Status Completed
Enrollment 111
Est. completion date November 2015
Est. primary completion date July 2015
Accepts healthy volunteers No
Gender Both
Age group 8 Years to 14 Years
Eligibility Inclusion Criteria:

- In grades 3 through 8 and attending one of the 11 participating public schools

- Age 8 through 14 years

- Qualify for the free or reduced cost school lunch program in Pennsylvania (families that receive food stamps or have an annual income of < $40,900).

- Meets National Heart Lung and Blood Institute (NHLBI, 2007) criteria for any asthma diagnosis EXCEPT mild, intermittent asthma, as confirmed by the study physician using NHLBI Guidelines for the Diagnosis and Management of Asthma (http://www.nhlbi.nih.gov/guidelines/asthma/asthsumm.pdf, page 40).

- Has a parent or legal guardian who is willing to participate in the study

- Fluent in English (i.e., have commonly used English in everyday speaking and reading for at least 10 years)

Exclusion Criteria:

- History of a chronic illness in addition to asthma (determined by parent or guardian report)

- Prescribed medications other than for asthma

- Mental retardation or significant developmental delay

- Inability to speak or understand English

- A diagnosis of mild, intermittent asthma as determined using NHLBI (2007) criteria (see above)

- Age less then 8 years or greater than 14 years

- Not in grades 3 through 8

- Not qualifying for free or reduced cost school lunches in Pennsylvania

- No parent or legal guardian who is willing to participate

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Behavioral:
I Can Cope Intervention
Participants randomized to the "I Can Cope" condition will receive 6 face-to-face individualized sessions over a 2-month period. Each session will last 50 minutes and take place at the child's school either during approved times during the school day or as part of the after-school program. Sessions are psychoeducational and experiential and include opportunities for the child with asthma to: (1) learn about the pathophysiology of asthma; (2) understand the biological impact of stress on the body; (3) learn the relationship among thoughts, feelings, actions, and asthma; (4) acquire a set of coping skills to help deal with asthma-related and day-to-day stressors in their lives, and (5) receive training in biofeedback-assisted relaxation techniques.
Standard Education Intervention
This group will receive the standard American Lung Association (ALA)"Open Airways for Schools" program. This program includes six 40-minute sessions covering the National Heart Lung and Blood Institute's recommendations for asthma education.

Locations

Country Name City State
United States University of Pittsburgh Pittsburgh Pennsylvania

Sponsors (1)

Lead Sponsor Collaborator
University of Pittsburgh

Country where clinical trial is conducted

United States, 

References & Publications (1)

Long KA, Ewing LJ, Cohen S, Skoner D, Gentile D, Koehrsen J, Howe C, Thompson AL, Rosen RK, Ganley M, Marsland AL. Preliminary evidence for the feasibility of a stress management intervention for 7- to 12-year-olds with asthma. J Asthma. 2011 Mar;48(2):162-70. doi: 10.3109/02770903.2011.554941. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Proportion of Eligible Children who Participate in Study A measure of the feasibility of offering the "I Can Cope" intervention trial to socioeconomically disadvantaged 8-14 year-old children with physician-confirmed asthma in urban schools. End of enrollment: estimated 2 years after beginning active enrollment. No
Primary Participant Drop-out Rates A measure of the feasibility of offering the "I Can Cope" intervention trial to socioeconomically disadvantaged 8-14 year-old children with physician-confirmed asthma in urban schools. After final outcome measures are collected: up to 2 1/2 years from beginning of active enrollment. No
Primary Session Completion Rates A measure of the feasibility of offering the "I Can Cope" intervention trial to socioeconomically disadvantaged 8-14 year-old children with physician-confirmed asthma in urban schools. After final participant has completed study: estimated 2 1/2 years after beginning active enrollement. No
Primary Program Satisfaction Survey End of Study Participation: up to 5 months from initial enrollment. No
Primary Barriers to offering the Intervention in Selected Schools End of enrollment: estimated 2 years after beginning active enrollment. No
Primary Child Depression Inventory Assess change in symptoms of depression. Pre and Post Intervention: baseline, up to 4 months later. Yes
Primary State-Trait Anxiety Inventory for Children Assess change in symptoms of anxiety and depression. Pre and Post Intervention: baseline, up to 4 months later. No
Primary Perceived Stress Scale Assess change in the degree to which the child perceives current demands as stressful and exceeding his or her ability to cope. Pre and post intervention: baseline, up to 4 months later. No
Primary Pediatric Asthma Quality of Life Questionnaire Assesses asthma-related quality of life. Pre and Post Intervention: baseline, up to 4 months later. No
Primary Asthma Self-Management Scale Parent and child participants will complete the which assesses beliefs that they can perform behaviors to alleviate the child's asthma, including behaviors associated with symptom prevention (e.g., getting to doctor, using medication, and avoiding allergens) as well as symptom management (e.g., staying calm, controlling symptoms, deciding how to manage symptoms). Pre and Post Intervention: baseline, up to 4 months later. No
Primary KIDCOPE Child participants will complete the Kidcope a 10-item measure of different coping strategies. Pre and Post Intervention: baseline, up to 4 months later. No
Primary Measure of Current Status (MOCS - Adapted) In order to measure the effectiveness of stress management training, child participants will complete an adapted version of the 10-item Measure of Current Status assessing perceived self-efficacy for skills targeted by the intervention: the ability to relax, to recognize stress-inducing situations, to be assertive about needs, and to choose appropriate coping responses. Pre and Post Intervention: baseline, up to 4 months later. No
Primary Change in Asthma Health from Baseline The magnitude of intervention-related improvements in the child's asthma health will be measured by change in pulmonary function, exhaled levels of nitric oxide, and symptoms of asthma, as well as number of medical visits, and school absenteeism. Pre to post-intervention: baseline, up to 4 months later. No
Secondary Life Events Questionnaire Assesses life events that have had a negative impact on the child's psychological state. Baseline No
See also
  Status Clinical Trial Phase
Terminated NCT04410523 - Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma Phase 2
Completed NCT04624425 - Additional Effects of Segmental Breathing In Asthma N/A
Active, not recruiting NCT03927820 - A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR) N/A
Completed NCT04617015 - Defining and Treating Depression-related Asthma Early Phase 1
Recruiting NCT03694158 - Investigating Dupilumab's Effect in Asthma by Genotype Phase 4
Terminated NCT04946318 - Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma Phase 2
Completed NCT04450108 - Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients N/A
Completed NCT03086460 - A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH) Phase 2
Completed NCT01160224 - Oral GW766944 (Oral CCR3 Antagonist) Phase 2
Completed NCT03186209 - Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE) Phase 3
Completed NCT02502734 - Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma Phase 3
Completed NCT01715844 - L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics Phase 1
Terminated NCT04993443 - First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036 Phase 1
Completed NCT02787863 - Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology Phase 4
Recruiting NCT06033833 - Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study Phase 2
Completed NCT03257995 - Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma. Phase 2
Completed NCT02212483 - Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients N/A
Recruiting NCT04872309 - MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
Withdrawn NCT01468805 - Childhood Asthma Reduction Study N/A
Recruiting NCT05145894 - Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device